The cannabinoid receptors
- 1 August 2002
- journal article
- review article
- Published by Elsevier BV in Prostaglandins & Other Lipid Mediators
- Vol. 68-69, 619-631
- https://doi.org/10.1016/s0090-6980(02)00060-6
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- Despite substantial degradation, 2‐arachidonoylglycerol is a potent full efficacy agonist mediating CB1 receptor‐dependent G‐protein activation in rat cerebellar membranesBritish Journal of Pharmacology, 2001
- The neurobiology and evolution of cannabinoid signallingPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2001
- Highly Selective CB1 Cannabinoid Receptor Ligands and Novel CB1/VR1 Vanilloid Receptor “Hybrid” LigandsBiochemical and Biophysical Research Communications, 2001
- Mesenteric Vasodilation Mediated by Endothelial Anandamide ReceptorsHypertension, 1999
- Antagonism of LPS and IFN-γ Induction of iNOS in Human Saphenous Vein Endothelium by Morphine and Anandamide by Nitric Oxide Inhibition of Adenylate CyclaseJournal of Cardiovascular Pharmacology, 1998
- Inhibition by 2-Arachidonoylglycerol, a Novel Type of Possible Neuromodulator, of the Depolarization-Induced Increase in Intracellular Free Calcium in Neuroblastoma × Glioma Hybrid NG108-15 CellsBiochemical and Biophysical Research Communications, 1997
- 2-Arachidonoylglycerol, a Putative Endogenous Cannabinoid Receptor Ligand, Induces Rapid, Transient Elevation of Intracellular Free Ca2+in Neuroblastoma × Glioma Hybrid NG108-15 CellsBiochemical and Biophysical Research Communications, 1996
- The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein couplingFEBS Letters, 1995
- The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamideFEBS Letters, 1995
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorFEBS Letters, 1994